相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ACOG Practice Bulletin No. 109: Cervical Cytology Screening
OBSTETRICS AND GYNECOLOGY (2014)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions
Susan Hariri et al.
CANCER CAUSES & CONTROL (2012)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
Mark H. Stoler et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV plus Cytology-Negative Results
Thomas C. Wright et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study
Mark Schiffman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial
Henry C. Kitchener et al.
EUROPEAN JOURNAL OF CANCER (2011)
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication
Ni Li et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines
Otis Brawley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer
Hui-Chi Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Hormuzd A. Katki et al.
LANCET ONCOLOGY (2011)
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Philip E. Castle et al.
LANCET ONCOLOGY (2011)
Comparative community outreach to increase cervical cancer screening in the Mississippi Delta
Philip E. Castle et al.
PREVENTIVE MEDICINE (2011)
The cost-effectiveness of male HPV vaccination in the United States
Harrell W. Chesson et al.
VACCINE (2011)
Special Commentary Patient Safety and the Next Generation of HPV DNA Tests
Walter Kinney et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
High-Risk HPV Testing in Women 30 Years or Older With Negative Papanicolaou Tests Initial Clinical Experience With 18-Month Follow-up
Michael J. Thrall et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Cervical Cancer Screening With Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone What Screening Intervals Are Physicians Recommending?
Mona Saraiya et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2010)
Cost-effectiveness of human papillomavirus vaccination and screening in Spain
Mireia Diaz et al.
EUROPEAN JOURNAL OF CANCER (2010)
Predictors of human papillomavirus persistence among women with equivocal or mildly abnormal cytology
Delphine Maucort-Boulch et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Practice Improvement in Cervical Screening and Management: Symposium on Management of Cervical Abnormalities in Adolescents and Young Women
Philip E. Castle et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2010)
Practice Improvement in Cervical Screening and Management (PICSM): Symposium on Management of Cervical Abnormalities in Adolescents and Young Women
Anna-Barbara Moscicki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2010)
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
Susanne K. Kjaer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
Nubia Munoz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2010)
The Age-Specific Relationships of Abnormal Cytology and Human Papillomavirus DNA Results to the Risk of Cervical Precancer and Cancer
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2010)
Triage of Women with Minor Cervical Lesions: Data Suggesting a Test and Treat Approach for HPV E6/E7 mRNA Testing
Sveinung Wergeland Sorbye et al.
PLOS ONE (2010)
Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme
Ahti Anttila et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
The efficacy of HPV 16/18 vaccines on sexually active 18-23 year old women and the impact of HPV vaccination on organized cervical cancer screening
Kristjan Sigurdsson et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2009)
The Expected Impact of HPV Vaccination on the Accuracy of Cervical Cancer Screening: The Need for a Paradigm Change
Eduardo L. Franco et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model-based cost-effectiveness
Veerle M. H. Coupe et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
Chris J. L. M. Meijer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Cost-effectiveness of human papillomavirus vaccination in Belgium: Do not forget about cervical cancer screening
Nancy Thiry et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2009)
Comparison of Liquid-Based Cytology With Conventional Cytology for Detection of Cervical Cancer Precursors A Randomized Controlled Trial
Albertus G. Siebers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
Darron R. Brown et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States
Cosette M. Wheeler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Cervical Intraepithelial Neoplasia Outcomes After Treatment: Long-term Follow-up From the British Columbia Cohort Study
Joy Melnikow et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
Maarit Leinonen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years
B. Romanowski et al.
LANCET (2009)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J. Paovonen et al.
LANCET (2009)
Further analysis of the ARTISTIC trial
Peter Sasieni et al.
LANCET ONCOLOGY (2009)
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
Henry C. Kitchener et al.
LANCET ONCOLOGY (2009)
Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
Economic Evaluation of Human Papillomavirus Vaccination in Developed Countries
Marc Brisson et al.
PUBLIC HEALTH GENOMICS (2009)
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study
Philip E. Castle et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
Peter Sasieni et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005
S. Deblina Datta et al.
ANNALS OF INTERNAL MEDICINE (2008)
Trade-offs in cervical cancer prevention - Balancing benefits and risks
Natasha K. Stout et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
V. M. H. Coupe et al.
BRITISH JOURNAL OF CANCER (2008)
Descriptive Epidemiology of Vaginal Cancer Incidence and Survival by Race, Ethnicity, and Age in the United States
Xiaocheng Wu et al.
CANCER (2008)
Total Burden and Incidence of In Situ and Invasive Cervical Carcinoma in Michigan, 1985-2003
Glenn Copeland et al.
CANCER (2008)
Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain
Aline Gauthier et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2008)
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
Jeremy D. Goldhaber-Fiebert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial
Francesca Carozzi et al.
LANCET ONCOLOGY (2008)
Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
Margaret R. E. McCredie et al.
LANCET ONCOLOGY (2008)
Liquid compared with conventional cervical cytology - A systematic review and meta-analysis
Marc Arbyn et al.
OBSTETRICS AND GYNECOLOGY (2008)
GRADE:: going from evidence to recommendations
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
GRADE:: what is quality of evidence and why is it important to clinicians?
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joalim Dillner et al.
BRITISH MEDICAL JOURNAL (2008)
Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis
M. Arbyn et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
N. W. J. Bulkmans et al.
LANCET (2007)
Potential effects of decreased cervical cancer screening participation after HPV vaccination: An example from the US
Shalini L. Kulasingam et al.
VACCINE (2007)
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection
Luisa L. Villa et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer
Marie-Helene Mayrand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program
Shalini Kulasingam et al.
SEXUAL HEALTH (2007)
Process of care failures in invasive cervical cancer: Systematic review and meta-analysis
Andrea R. Spence et al.
PREVENTIVE MEDICINE (2007)
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada
Marc Brisson et al.
VACCINE (2007)
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ:: a combined analysis of four randomised clinical trials
L. Villa et al.
LANCET (2007)
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance
Mahboobeh Safaeian et al.
OBSTETRICS AND GYNECOLOGY (2007)
A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion
Martyn Plummer et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses - An ALTS report
Philip E. Castle et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays
Mark H. Stoler et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Prevalence of HPV infection among females in the United States
Eileen F. Dunne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix:: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies
Amy Berrington de Gonzalez et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Model for assessing human papillomavirus vaccination strategies
Elamin H. Elbasha et al.
EMERGING INFECTIOUS DISEASES (2007)
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: A systematic review and meta-analysis of non-randomized studies
George Koliopoulos et al.
GYNECOLOGIC ONCOLOGY (2007)
American Cancer Society guideline for human papillornavirus (HPV) vaccine use to prevent cervical cancer and its precursors
Debbie Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period
Susanne Kjaer et al.
CANCER RESEARCH (2006)
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
Jack Cuzick et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia
WP Soutter et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention
X Castellsagué et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Reproducibility of HPV DNA testing by hybrid capture 2 in a screening setting - Intralaboratory and interlaboratory quality control in seven laboratories participating in the same clinical trial
FM Carozzi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Incidence trends of adenocarcinoma of the cervix in 13 European countries
F Bray et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
The development of a quality assurance programme for HPV testing within the UKNHS cervical screening LBC/HPV studies
HA Cubie et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities
PE Castle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
MJ Khan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Spontaneous regression of high-grade cervical dysplasia: Effects of human papillomavirus type and HLA phenotype
CL Trimble et al.
CLINICAL CANCER RESEARCH (2005)
Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy
JJ Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Cervical cancer in women with comprehensive health care access: Attributable factors in the screening process
WA Leyden et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Screening for cervical cancer: Will women accept less?
BE Sirovich et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
SJ Goldie et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more
SJ Goldie et al.
OBSTETRICS AND GYNECOLOGY (2004)
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000
SS Wang et al.
CANCER (2004)
The predicted effect of changes in cervical screening practice in the UK: results from a modelling study
K Canfell et al.
BRITISH JOURNAL OF CANCER (2004)
Interlaboratory reliability of Hybrid Capture 2
PE Castle et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Management of women who test positive for high-risk types of human papillomavirus: the HART study
J Cuzick et al.
LANCET (2003)
Risk of cervical cancer associated with extending the interval between cervical-cancer screenings
GF Sawaya et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Potential health and economic impact of adding a human papillomavirus vaccine to screening programs
SL Kulasingam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
P Sasieni et al.
BRITISH JOURNAL OF CANCER (2003)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Screening interval and risk of invasive squamous cell cervical cancer
MG Miller et al.
OBSTETRICS AND GYNECOLOGY (2003)
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis
ME Sherman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
American Cancer Society guideline for the early detection of cervical neoplasia and cancer
D Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2002)
HPV for cervical cancer screening: Is the era of the molecular Pap smear upon us?
MH Stoler
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2001)
Determinants of genital human papillomavirus detection in a US population
CL Peyton et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Interobserver reproducibility of cervical cytologic and histologic interpretations - Realistic estimates from the ASCUS-LSIL triage study
MH Stoler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Frequency of cervical smear abnormalities within 3 years of normal cytology
GF Sawaya et al.
OBSTETRICS AND GYNECOLOGY (2000)
分享论文
